An Open, Phase III Study of Lanreotide (Somatuline PR^<【○!R】>) in the Treatment of Acromegaly
スポンサーリンク
概要
著者
-
Lin Jen-der
Division Of Endocrinology & Metabolism Department Of Internal Medicine Chang Gung Memorial Hospi
-
Weng Hsiao-fen
Division Of Endocrinology And Metabolism Department Of Internal Medicine Chang Gung Memorial Hospita
-
Weng Hsiao-fen
Division Of Endocrinology And Metabolism Department Of Internal Medicine Chang Gung Memorial Hospita
-
LEE Shih-Tseng
Division of Neurosurgery, Department of Surgery, Chang Gung Memorial Hospital
-
Lee Shih-tseng
Division Of Neurosurgery Department Of Surgery Chang Gung Memorial Hospital
関連論文
- The effects of weekly alendronate therapy in Taiwanese males with osteoporosis
- The Relationship between Serum Uric Acid Level and Metabolic Syndrome : Differences by Sex and Age in Taiwanese
- Correlation of the Dysmetabolic Risk Factors with Different Anthropometric Measurements
- Prognosis and Risk Stratification in Young Papillary Thyroid Carcinoma Patients
- Prognostic Variables of Papillary Thyroid Carcinomas with Local Invasion
- Follicular Thyroid Carcinomas with Lung Metastases : A 23-Year Retrospective Study
- Follicular Thyroid Carcinoma : From Diagnosis to Treatment
- The Influence of Long-Term Different Diabetic Therapies on Plasma Leptin in Type 2 Diabetic Subjects
- An Open, Phase III Study of Lanreotide (Somatuline PR^) in the Treatment of Acromegaly
- Neck nodule and thyroid cancer in young without radiation exposure history
- Long-Term Effects of Ketoconazole in the Treatment of Residual or Recurrent Cushing's Disease